Amanda Darekar

Comparison of Different Algorithms for Predicting Clinical Drug-Drug Interactions, Based on the Use of CYP3A4 in Vitro Data: Predictions of Compounds as Precipitants of Interaction

Odette A. Fahmi, Susan Hurst, David R. Plowchalk et al. · Drug Metabolism and Disposition · 2009 · 210 citations

Effect of ertugliflozin on glucose control, body weight, blood pressure and bone density in type 2 diabetes mellitus inadequately controlled on metformin monotherapy ( <scp>VERTIS MET</scp> )

Julio Rosenstock, Juan P. Frías, Dénes Páll et al. · Diabetes Obesity and Metabolism · 2017 · 184 citations · Full text

Phase III, efficacy and safety study of ertugliflozin monotherapy in people with type 2 diabetes mellitus inadequately controlled with diet and exercise alone

Steven G. Terra, Kristen Focht, Melanie J. Davies et al. · Diabetes Obesity and Metabolism · 2017 · 141 citations

Flexible‐Dose Fesoterodine in Elderly Adults with Overactive Bladder: Results of the Randomized, Double‐Blind, Placebo‐Controlled Study of Fesoterodine in an Aging Population Trial

Adrian Wagg, Vik Khullar, Daniela Marschall‐Kehrel et al. · Journal of the American Geriatrics Society · 2013 · 103 citations

Application of CYP3A4<i>in vitro</i>data to predict clinical drug–drug interactions; predictions of compounds as objects of interaction

Kuresh Youdim, Aref Zayed, Maurice Dickins et al. · British Journal of Clinical Pharmacology · 2008 · 95 citations · Full text